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CD4þ T cells play a critical role in allergic diseases, both in the affected tissue as well as systemically. Our
objective was to investigate the in vivo activation state of peripheral blood CD4þ T cells of atopic dermatitis (AD)
patients by analyzing gene expression proﬁles of unstimulated CD4þ T cells. mRNA samples from blood CD4þ T
cells, isolated from ﬁve AD patients and seven healthy controls (HC), were analyzed using oligonucleotide arrays.
Differentially regulated genes were validated by quantitative PCR (Q-PCR) in a larger group of patients with AD, in a
group of patients with allergic asthma (AA), and HC subjects. In addition, ‘‘typical’’ T helper type 1 (Th1)- and Th2-
related genes were analyzed by Q-PCR. Microarray analysis revealed differential expression of 52 genes in AD
patients. Q-PCR conﬁrmed several differentially regulated genes in AD, including CCR10, CRTH2, C-JUN, and
NR4A2. Two groups of genes with highly correlating gene expression levels involved in tissue homing and pro-
liferation or apoptosis, respectively, were identiﬁed. No marked differences were found in gene expression levels of
typical Th1 or Th2 genes in AD or in AA patients. This study demonstrates that peripheral blood, unstimulated
CD4þ T cells in AD patients show differentially expressed genes involved in tissue homing, proliferation, and
apoptosis. No marked expression differences of ‘‘typical’’ atopy genes were found.
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Atopic dermatitis (AD) and allergic asthma (AA) are com-
mon, chronic, allergic inflammatory diseases. AD is char-
acterized by chronically persistent, as well as recurrent,
pruritic, erythematous skin lesions. AD skin lesions typically
show infiltration of immune cells, particularly CD4þ T cells,
in the dermis and epidermis, suggested to induce apoptosis
of keratinocytes, resulting in spongiosis, which is the his-
tological hallmark of eczema (Trautmann et al, 2000). CD4þ
T cells have also been shown to play a pivotal role in the
initiation and maintenance of inflammation in the asthmatic
airways (Larche et al, 2003).
CD4þ T cells can be divided into T helper type 1 (Th1)
and Th2 subsets, according to their cytokine secretion pro-
file. Atopic diseases have been associated with a systemic
Th2-cytokine predominance, contributing to high IgE levels
and blood eosinophilia. However, investigating T cell pop-
ulations in lesional AD skin has revealed a more complex
picture than suggested by the classic Th1/Th2 paradigm,
characterized by a Th2 profile in acute eczema and a Th1
profile in chronic eczema lesions (Grewe et al, 1998).
The restricted expression of cytokines by polarized T cell
subsets arises from the differential expression of transcrip-
tion factors. GATA-3 is expressed during Th2 differentiation
via pathways that probably involve the interleukin (IL)-4-de-
pendent activation of signal transducers and activators of
transcription (STAT-6). In addition, GATA-3 transactivates
the expression of genes for IL-5 and IL-13 directly in Th2
cells. T-BET is expressed exclusively in Th1 cells and its ex-
pression is mediated mainly by a STAT-4-dependent path-
way inducing production of IFNG (Rengarajan et al, 2000).
Different subpopulations of CD4þ T cells have been
shown to manifest preferential migration into tissues, such
as skin versus lung. A preferential skin-homing memory T
cell subset was characterized by expression of cutaneous
lymphocyte antigen (CLA) (Picker et al, 1990). Compared
with peripheral blood, CLAþ memory T cells were shown to
be highly enriched (expressed by 80%–90%) in skin, but not
in other organs, like the lungs. Chemokines, a protein su-
perfamily of structurally related small secreted proteins,
have been shown to regulate the trafficking of distinct le-
ukocyte subsets into peripheral tissues (Homey and Zlotnik,
1999). CC chemokine receptors (CCR4 and CCR10)
have recently been suggested to play a sequential role in
the recruitment pathway of skin-homing T cells in AD1These authors contributed equally.
Abbreviations: AA, allergic asthma; AD, atopic dermatitis; CCL, CC
chemokine ligand; CCR, CC chemokine receptor; CLA, cutaneous
lymphocyte antigen; FDR, false discovery rate; HC, healthy control;
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patients (Reiss et al, 2001). Furthermore, chemokines TARC
(CCL17) and CTACK (CCL27) have been found to be in-
creased in the serum of patients with AD, but not with AA
(Hijnen et al, 2004).
To achieve a better understanding of the underlying
processes in atopic diseases, several molecular approach-
es are currently being utilized. Genetic studies have iden-
tified several genes related to allergic diseases. In AD
linkage was demonstrated to the high-affinity IgE receptor
(FCER1B) and to genes on chromosomes 1q21, 17q25, and
20p, previously found to be related to psoriasis (Folster-
Holst et al, 1998; Cookson et al, 2001). ADAM33 was re-
cently found to show linkage to AA, although its role in AA
largely remains unknown (Van Eerdewegh et al, 2002). De-
spite the identification of several atopic disease-related
susceptibility loci, specific genes that play a causative role
in disease progression still have to be identified. Genomics
represents a promising approach that is being increasingly
used to unravel the pathogenesis of complex diseases by
the observation of gene expression. Much effort has been
put in the investigation of gene expression in differentiated
T cells of various types. Most data have been obtained
by using established T cell lines, or at least T cells that
have been cultured in vitro for some time (Nagata et al,
2003; Wohlfahrt et al, 2003). Relatively few experiments
have addressed the question of gene expression of un-
stimulated peripheral blood T cells in atopic diseases
(Matsumoto et al, 2002).
The aim of this study was to investigate the in vivo ac-
tivation state of peripheral blood CD4þ T cells in AD, by
comparing differential gene expression profiles of unstim-
ulated peripheral blood CD4þ Tcells of AD and AA patients
with gene expression patterns of HC.
Results
In order to investigate differential gene expression in CD4þ
T cells from AD patients, we compared gene expression
profiles of CD4þ T cells from AD patients with healthy
control (HC). Using SAM software, 52 genes with a false
discovery rate (FDR) of less than 50% were found to show
at least 1.5-fold increased or decreased expression in AD
compared with HC (Table I). Expressed sequence tags, hy-
pothetical genes, and genes with an unknown function were
excluded from this list. From the list of genes found to be
differentially expressed, 20 demonstrated a higher expres-
sion in AD compared with HC. Furthermore, 32 genes were
found to have a decreased expression in AD compared with
HC. To confirm gene expression changes observed by mi-
croarray analysis, quantitative PCR (Q-PCR) analysis was
performed on a selection of genes in larger groups of AD
patients and HC. Furthermore, Q-PCR analysis was ex-
tended to a group of patients with AA (without AD).
For Q-PCR validation we chose 10 genes that showed a
relatively low Q-value and a high fold change (TYMS, FUCT-
VII, NR4A2, TNFAIP3, ZNF331, GADD45A, JUNB, DUSP2,
ZFP36, CXCR4, C-JUN), two genes (CRTH2 and CCR10)
that have been suggested to be involved in the pathogen-
esis of AD (Iwasaki et al, 2002; Vestergaard et al, 2003),
and one gene (FCER1A) that was unexpectedly showing
differential regulation in the microarray analysis. Q-PCR
analysis showed statistically significant increased expres-
sion of CCR10 (3.0-fold) and CRTH2 (1.8-fold), and
decreased expression of NR4A2 (4.9-fold), GADD45A (2.4-
fold), TNFAIP3 (3.4-fold), JUNB (2.5-fold), and C-JUN (5.7-
fold) in AD patients. But, Q-PCR analysis could not confirm
statistically significant differential expression for FUCT-VII,
FCERIA, TYMS, DUSP2, ZFP36, CXCR4, and ZFP331.
None of the 13 genes studied by Q-PCR analysis were
found to be differentially expressed in the AA patient group.
By Q-PCR no differential expression of FCER1A was found.
Because AD and AA are classically defined as Th2-me-
diated diseases, and the microarray analysis did not reveal
differential expression of genes known to be associated
with a Th2 phenotype, a selection of Th1- and Th2-related
genes was analyzed by Q-PCR. We studied expression of
transcription factors controlling Th1 and Th2 development
(STAT-4, T-BET, STAT-6, and GATA-3), Th1 and Th2
cytokines (IFN-g, IL-4, IL-5, IL-10, and IL-13), and CCR4
(which has been described to be preferentially expressed
on Th2 cells (Bonecchi et al, 1998) (Table II). By Q-PCR
analysis no statistically significant differential expression of
typical Th1 or Th2 transcription factors and cytokines was
found. CCR4 showed a statistically significant 2.3-fold in-
creased expression in AD patients compared with HC. Th2-
cytokines IL-4, IL-5, and IL-13 were expressed below the
detection level.
Correlation coefficients between gene expression levels,
determined by Q-PCR, of a selection of genes (showing at
least 1.5-fold increased or decreased expression) are listed
in supplementary Table S3. Two groups of genes with highly
correlating gene expressions were found (Fig 1). The first
group includes genes, with increased expression in AD
compared with HC, that are suggested to be important for
homing of T cells to the skin: FUCT-VII, CRTH2, and CCR10.
Gene expression levels of a second group of genes, in-
cluding NR4A2, CJUN, JUNB, GADD45A, TNFAIP3, and
DUSP2, showing decreased expression in AD compared
with HC, were also found to correlate highly (Fig 1B).
Discussion
AD and AA are systemic diseases in which CD4þT cells
play a pivotal role (Kay, 2001; Leung et al, 2004). Much effort
has been put in the investigation of established T cell lines,
or primary T cells that have been cultured in vitro. The lim-
ited amount of RNA that can be retrieved from primary T
cells has been a pitfall in the investigation of gene expres-
sion in primary cells (Wohlfahrt et al, 2003). But, the intro-
duction of mRNA amplification has enabled gene profiling of
primary cell populations, with the possibility to understand
the physiologic status of these cells in vivo. Using mRNA
amplification, Matsumoto et al (2002) recently showed dif-
ferential gene expression (using fluorescent differential dis-
play) in CD3þ T cells from children with AD or AA. In their
study, 15 genes being differentially expressed in both AD
and AA children were described. However, no genes ex-
clusively regulated in AD patients were found. By additional
RT-PCR analysis, on genes known to be involved in atopy,
increased expression of CCR4, decreased expression of
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GATA3, and no differences for TBET and IFNG in CD3þ T
cells from AD children were found.
This study is the first to investigate gene expression pat-
terns that characterize freshly isolated, unstimulated CD4þ
T cells from adult AD patients. Microarray analysis demon-
strated 52 differentially expressed genes in AD patients.
Subsequent Q-PCR analysis confirmed differential expres-
sion of several genes in AD. As these genes were found
differentially expressed in AD and not in AA patients, they
seem to be related specifically to AD, rather than associated
with atopy.
Microarray analysis revealed differential gene expression
of FCER1A in CD4þ T cells from AD patients. This might
suggest contamination by FCER1A expressing plasma-
cytoid dendritic cells (pDC). But, FACS analysis excluded
Table II. Fold changes in differential gene expression of
Th1- and Th2-related genes in CD4þ T cells in AD (n¼ 8)
and AA (n¼ 8) patients compared with HC (n¼ 11)
AD versus HC AA versus HC
Fold change p-valueb Fold change p-valueb
CCR4 2.3 0.005 1.2 NS
GATA-3 1.2 NS 1.1 NS
IFNG 1.3 NS 1.2 NS
IL-10 1.4 NS 1.3 NS
IL-13 a a a a
IL-4 a a a a
IL-5 a a a a
STAT-4 1.5 NS 1.4 NS
STAT-6 1.0 NS 1.1 NS
T-BET 1.0 NS 1.2 NS
aNot detectable.
bPairwise fixed reallocation randomization test.
NS, not statistically significant; Th1, T helper type 1; AD, atopic der-
matitis; AA, allergic asthma; CCR4, CC chemokine receptor 4; IL, inter-
leukin; STAT, signal transducers and activators of transcription.
Table I. Differentially expressed genes in atopic dermatitis
compared to healthy controls
Abbreviation Genbank Fold change q-value (%)
Increased
TYMS NM_001071 2.7 12.9
FUT7 NM_004479 1.9 12.9
S100A11 NM_005620 1.6 12.9
ANX2P2 — 1.9 23.0
FCER1A NM_002001 2.0 27.9
CST3 NM_000099 1.7 27.9
IFI30 NM_006332 1.6 27.9
HLA-DRB1 NM_002124 1.5 27.9
SPI1 NM_003120 1.5 27.9
FCER1G NM_004106 2.0 30.4
LGALS1 NM_002305 1.9 30.4
CRTH2 NM_004778 1.8 30.4
CD74 NM_004355 1.5 30.4
HN1 NM_016185 1.6 33.2
SPAG1 NM_003114 1.6 33.2
CPVL NM_031311 1.6 36.3
HLA-DRB5 NM_002125 1.5 36.3
AHNAK – 1.6 39.7
HLA-DRA NM_019111 1.5 39.7
CCR10 NM_016602 1.8 47.5
Decreased
NR4A2 NM_006186 9.1 6.7
ZNF331 NM_018555 3.4 6.7
GADD45A NM_001924 3.2 6.7
TNFAIP3 NM_006290 3.2 6.7
JUNB NM_002229 3.1 6.7
DUSP2 NM_004418 2.4 6.7
ZFP36 NM_003407 2.2 6.7
BRF2 NM_006887 2.2 6.7
SBDS NM_016038 1.9 6.7
CXCR4 NM_003467 1.8 6.7
CJUN NM_002228 2.9 12.9
RNF139 NM_007218 1.9 12.9
NY-REN-7 NM_173663 1.6 12.9
FC(GAMMA)BP NM_003890 2.2 16.7
HLA-DQA1 NM_002122 1.8 16.7
TAF7L NM_024885 1.7 16.7
RRN3 NM_018427 1.6 16.7
PER1 NM_002616 2.3 23.0
LAP70 NM_004901 1.9 23.0
PHF1 NM_002636 1.7 23.0
H3F3A NM_002107 1.6 23.0
Table I. Continued
Abbreviation Genbank Fold change q-value (%)
SUI1 NM_005801 1.6 23.0
RNF138 NM_016271 1.6 27.9
IDI1 NM_004508 1.6 33.2
PDE4B NM_002600 1.6 33.2
HSPC297 NM_021237 1.6 36.3
HSF2 NM_004506 1.9 39.7
ZNF395 NM_018660 1.5 39.7
DEFA1 NM_004084 2.5 43.9
DUSP1 NM_004417 1.8 43.9
PCDHGB4 NM_003736 1.5 43.9
IGKV1D-8 – 1.7 47.5
In bold genes validated by quantitative PCR (Q-PCR).
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contamination by pDC (data not shown). Q-PCR confirmed
expression of FCER1A in CD4þ T cells (which had also
been described by Nakajima et al, 2004); however, no dif-
ferential expression of FCER1A between AD patients and
HC could be detected.
In addition, Q-PCR analysis revealed two groups of
genes with highly correlating gene expression levels. One
group includes genes known to be involved in skin homing
of T cells, whereas the other group includes genes sug-
gested to be involved in apoptosis or proliferation. The first
group includes FUCTVII, CRTH2, and CCR10, showing in-
creased expression in AD (Fig 1A). Expression of FUCT-VII
has been suggested to regulate CLA expression (Nakayama
et al, 2000), important for homing of CD4þTcells to the skin
in AD. Chemokine receptor CCR10 has also been proposed
as a critical mediator of skin-specific T cell homing (Homey
et al, 2002). Furthermore, CTACK (CCL27), the ligand
for CCR10, was found to be increased in the serum of AD
patients (Kakinuma et al, 2001, 2002; Hijnen et al, 2004).
The receptor for prostaglandin D2, CRTH2, has also been
suggested to be involved in skin homing of T cells. Further-
more, a preferential increase of CRTH2 within the CLAþ T
cell population has been described in AD patients (Iwasaki
et al, 2002). Taken together, increased expression of
these genes in peripheral blood CD4þ T cells from AD pa-
tients suggesst a ‘‘pre-activated’’ status with increased po-
tential to migrate to the skin. This idea was further
supported by the detection of increased gene expression
of CCR4. As CCR4 expression on CD4þT cells has been
shown to correlate with disease severity in AD (Vestergaard
et al, 2000) and Matsumoto et al (2002) also showed
increased expression in CD3þ T cells, RT-PCR analysis
for CCR4 was performed. Furthermore, CLA expression
has been shown to correlate with CCR4 expression (Camp-
bell et al, 1999), and the ligands for CCR4 (TARC and
MDC) were found to be increased in the serum of patients
with AD (Galli et al, 2000; Kakinuma et al, 2001; Hijnen
et al, 2004).
Gene expression levels of a second subgroup of genes,
including NR4A2, DUSP2, TNFAIP3, C-JUN, JUNB, and
GADD45A, were also found to show significant correlating
gene expression levels. None of these genes have been
associated with AD before, and are thought to be in-
volved in regulating either proliferation or apoptosis (Fig 1B).
A role for NR4A2 in a signal transduction pathway mediat-
ing multiple inflammatory signals was suggested, after it
was found to show increased expression in the synovial
tissue in rheumatoid arthritis patients (McEvoy et al, 2002).
TNFAIP3 has been related to activation-induced cell
death in T cells via NF-kB (Malewicz et al, 2003). DUSP2
has been reported to be involved in p53-mediated
apoptosis (Yin et al, 2003). Jun family members are in-
volved in T cell activation, IL-2 expression and have been
implicated in Th2 polarization (Petrak et al, 1994; Harten-
stein et al, 2002). T cells in GADD45A knockout mice, which
develop an autoimmune disease similar to human systemic
lupus erythematosus, were found to have a lower threshold
for activation and proliferate to a greater extent after
primary T cell receptor stimulation (Salvador et al, 2002).
In a recent study, Akdis et al (2003) suggested that the
Th2 predominance in AD is because of increased apoptosis
of peripheral blood Th1-type cells. Taken together, differ-
entially regulated genes involved in apoptosis or proli-
feration described in this study might be related to
this phenomenon.
Our study suggests a ‘‘primed’’ state of peripheral blood
CD4þ T cells in AD patients. Previously, an in vivo activated
state of peripheral blood skin homing CD4þ T cells in AD
patients was described by Akdis et al (1997) characterized
by a spontaneous release of Th2 cytokines. Remarkably, the
microarray experiments revealed no increased expression
of typical Th2-related genes, which was confirmed by Q-
PCR analysis (Table II). These results suggest that periph-
eral blood CD4þ T cells from AD patients, although being
‘‘primed’’ for migration to the skin and showing differential
expression of genes involved in activation or proliferation,
do not show polarization towards a Th1- or Th2-cytokine
profile in vivo. Several studies that investigated AD or AA
patients support this observation. Differential gene expres-
sion analysis of unstimulated PBMC or CD3þ T cells from
AD patients did not show a marked Th2-type gene expres-
sion pattern (Heishi et al, 2002; Matsumoto et al, 2002).
Furthermore, in a genomic linkage analysis of a large pop-
ulation of AA patients, no Th2 gene involvement was found
(Van Eerdewegh et al, 2002). These results support our re-
sults that, although being primed for skin homing, peripheral
blood CD4þT cells from AD patients are not expressing
typical Th2-related genes.
Gene expression differences described in this study are
the result of differential expression of genes in the total
population of CD4þ T cells. Future research will elucidate if
these genes are preferentially expressed in subpopulation(s)
of CD4þ T cells, and how they contribute to the patho-
genesis of AD.
In conclusion, our results show that peripheral blood,
unstimulated CD4þ T cells in AD patients show differen-
tially expressed genes involved in tissue homing, prolifera-
tion, and apoptosis, but no marked expression differences
of ‘‘typical’’ atopy genes. Importantly, in peripheral blood
CD4þ T cells from AD patients, we describe two groups of
differentially expressed genes involved in T cell migration to
the skin and in proliferation or apoptosis, that might be im-
portant in the pathogenesis of AD.
Figure 1
Identification of two groups of genes with highly correlating gene
expressions. Lines represent statistically significant correlations (Pear-
sons’ correlation coefficient r40.70, po0.01, Methods) between
gene expression levels. (A) Genes involved in skin homing of T cells.
(B) Genes involved in apoptosis or proliferation. No statistically
significant differential expression levels found with Q-PCR analysis.
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Materials and Methods
Subjects for microarray analysis For the microarray analysis,
five patients, three females and two males, with chronic (extrinsic)
AD experiencing an exacerbation of disease (mean age, 43 y), who
fulfilled the criteria of Hanifin and Rajka (1980), were selected (Ta-
ble IIIA). Two patients also had allergic rhinitis, but none of the AD
patients had AA. All were polyallergic and had positive skin prick
tests to at least three aeroallergens. The patients were allowed to
use topical corticosteroids. None of the AD patients had systemic
immunosuppressive treatment at least 3 mo before peripheral ve-
nous blood was taken. Seven healthy non-allergic individuals, four
females and three males (mean age, 33 y), with no history of AD or
AA were included in the microarray study as a normal control
group. In AD patients, severity of the eczema was evaluated by the
Leicester sign score (LSS; range, 0–108), in which severity is
scored by six clinical features (erythema, purulence, excoriation or
crusting, dryness or scaling, cracking or fissuring, and lichenifi-
cation) graded at six defined body sites on a scale of 0 (none) to 3
(severe) (Sowden et al, 1991). Furthermore, serum TARC (CCL17)
levels were determined as an objective parameter for the severity
of eczema in AD patients, as previously described (Table IIIA)
(Hijnen et al, 2004).
Subjects for RT-PCR analysis Real-time RT-PCR analysis was
performed with AD patients and HC in addition to those included
for microarray analysis. Because RNA samples from two HC sub-
jects and one AD patient were no longer available for RT-PCR
analysis, six samples from different HC and four samples from
different AD patients were added to make up the RT-PCR analysis
set (Table IIIB). Furthermore, eight patients with a medical history of
AA (mean age, 37 y), as defined by the American Thoracic Society
(1987), were included, all patients had allergic rhinitis, but none of
the AA patients had AD. All AA subjects were polyallergic and had
positive skin prick tests to at least three aeroallergens. The AA
patients were allowed to use inhaled corticosteroids. The PC20,
histamine challenge test, was determined as a parameter for
bronchial hyperresponsiveness in AA patients. Eight patients, five
females and three males, with chronic (extrinsic) AD (mean age, 36
y), who fulfilled the criteria described above, were included. Three
patients also had allergic rhinitis, but none of the AD patients had
AA. None of the AD or AA patients had systemic immunosuppres-
sive treatment at least 3 mo before peripheral venous blood was
taken. Eleven healthy individuals, seven females and four males
(mean age, 34 y), with no history of AD or AA, were included in the
study as a healthy non-allergic control group (HC). Disease severity
parameters for AD (LSS and serum TARC levels) were determined
as described above. The medical ethical committee of the Univer-
sity Medical Center Utrecht approved all described studies and the
participants gave their written informed consent. The study was
conducted according to the Declaration of Helsinki Principles.
Cell isolation and RNA extraction PBMC were isolated by Ficoll
(Amersham, Uppsala, Sweden) density gradient centrifugation of
peripheral venous blood. Cells were washed three times and re-
suspended in PBS containing 2 mM EDTA (Merck, Germany) and
0.5% BSA (Sigma, St Louis, Missouri). After CD14 depletion using
the magnet activated cell separation system (MACS, Miltenyi Bio-
tech, Bergisch-Gladbach, Germany), CD4þ cells were isolated as
indicated by the manufacturer. In brief, anti-CD14-depleted cells
were incubated with MACS microbead-conjugated anti-CD4.
Table III. Clinical parameters of individuals in the (A) microarray experiments and (B) real-time PCR analysis
Age (years) Total IgE (kU per liter) LSS PC20 TARC (pg per mL)
(A) Microarray
Healthy controls (n¼7) 33  9 37  42 — — 136  46
Atopic dermatitis (n¼5) 43  10 8850  11281 34  6 — 6485  5449
(B) RT-PCR
Healthy controls (n¼11) 34  8 34  30 — — 128  35
Atopic dermatitis (n¼8) 36  11 4189  3176 26  17 — 1842  2019
Allergic asthma (n¼ 8) 37  9 363  485 — 3.7  3.1 171  184
LSS, Leicester sign score.
PC20, provocative concentration of histamine causing a 20% fall in FEV1.
All values are shown as mean  SD.
Table IV. Fold changes of differentially expressed genes in AD
patients (n¼ 8) and AA patients (n¼ 8), compared to healthy
controls (n¼ 11)
AD versus HC AA versus HC
Fold change p-valuea Fold change p-valuea
Upregulated
CCR10 3.0 0.001 1.2 NS
CRTH2 1.8 0.045 1.0 NS
FUCT-VII 1.5 NS 1.1 NS
FCERIA 1.1 NS 1.1 NS
TYMS 1.0 NS 1.1 NS
Downregulated
C-JUN 5.7 0.016 1.2 NS
NR4A2 4.9 0.020 1.2 NS
TNFAIP3 3.1 0.014 2.2 NS
JUNB 2.5 0.046 1.1 NS
GADD45A 2.4 0.050 1.1 NS
DUSP2 2.4 NS 1.0 NS
ZFP36 1.5 NS 1.1 NS
CXCR4 1.3 NS 1.1 NS
ZFP331 1.2 NS 1.1 NS
aPairwise fixed reallocation randomization test.
NS, not statistically significant; AD, Atopic dermatitis; AA, allergic
asthma; HC, healthy controls.
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Microbead-conjugated CD4þ T cells were then recovered from a
second MACS column. CD4þ cells wereX95% pure as assessed
by FACS analysis. Total RNA was extracted using Trizol (Invitrogen,
Carlsbad, California), according to the manufacturers protocol.
RNA ampliﬁcation, microarray analysis, and quantitative real-
time PCR RNA amplification and labeling were performed as de-
scribed previously (Roepman et al, 2005). The exact procedure is
available as supplementary data (Methods). Results of the micro-
array analysis are shown as fold change. The q-value determined
for each gene is the lowest FDR at which that gene is called sig-
nificant. It is like the well-known p-value, but adapted to multiple-
testing situations. q-values of the lowest possible FDR (o50%)
were used to generate a list of most relevant up- and downreg-
ulated genes. Finally, genes with an intensity value of at least
50 (which is about three times above the background signal), and
showing differential expression of at least 1.5-fold, were selected.
RT-PCR was performed for 25 genes (detailed information is
available as supplementary data (Methods), primers are shown in
Table S2). Results were normalized for PCR efficiency and for the
reference genes b-actin and GAPDH using relative expression
software tool (REST) (Pfaffl et al, 2002).
Statistical analysis Statistical significance of real-time PCR data
(Table IV, Table S3) was determined by REST software, using a
pairwise fixed reallocation randomization test (Pfaffl et al, 2002).
An associated probability (p-value) po0.05 was considered sig-
nificant. Correlations between mRNA expression levels were
calculated using Pearson’s correlation coefficient. Correlation
coefficients r40.7 (po0.01) were considered relevant.
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